About Sanifit
Sanifit is a Healthcare company based in Palma (Spain) founded in 2007, and was acquired by Vifor Pharma Benelux in November 2021. Drugs for cardiovascular, renal, osteoporosis, and oral-dental diseases are developed. Sanifit has raised $127.72 million across 4 funding rounds from investors including Baxter, Edmond de Rothschild and Andera Partners. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Drugs and Diversified.
Company details
Sanifit was founded in 2007 in Palma, Spain, and operates in the biopharmaceutical sector. Treatments for calcification disorders are developed, with SNF472 as the lead compound targeting cardiovascular calciphylaxis and end-stage renal disease in hemodialysis patients. The pipeline includes ASB-01 for oral tartar prevention, SNF671 tablets for bone health in osteoporosis, and Lit-Control, a device for renal lithiasis monitoring through urinary pH control.
- Headquarters Palma, Spain
- Stage Acquired
- SectorsHealthcare
- Website sanifit.com
- Social LinkedIn X
- Acquired by Vifor Pharma Benelux (Nov 2021)
- Total Equity Funding$127.72M (USD)
in 4 rounds
- Latest Funding Round$82.1M (USD), Series D
Jun 2019
- InvestorsBaxter
& 11 more
- Acquired byVifor Pharma Benelux
(Nov 2021)
Funding Insights of Sanifit
Sanifit has successfully raised a total of $127.72M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $82.1 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $127.72M
- Total Rounds 4
- Last Round Series D — $82.1M
- First Round $4.79M
(Aug 2014)
- Investors Count 11
All 4 funding rounds of Sanifit with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $82.1M | Series D | – | Caixa Capital Risc | |
| Sep 2015 | $40.83M | Series C | – | Ysios Capital | |
| Nov 2014 | Grant | – | – | – | |
| Aug 2014 | $4.79M | Series B | – | Caixa Capital Risc |
12 investors in total: 12 institutional.
Investors in Sanifit
Sanifit has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Baxter, Edmond de Rothschild and Andera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are focused on healthcare and multiple sectors. | caixacapitalrisc.es | Barcelona, Spain | ||
Columbus Venture Partners is focused on biotechnology investment funds. | columbusvp.com | Valencia, Spain | ||
| altals.com | ||||
Life science companies are funded through venture capital investments. | lundbeckfonden.com | Copenhagen, Denmark | ||
Private equity and venture captial firm focused on healthcare sectors | gildehealthcare.com | Cambridge, United States | ||
Ysios Capital is recognized as a leading life sciences investor. | ysioscapital.com | Barcelona, Spain | ||
Venture capital firm focused on lifescience and healthcare sectors | forbion.com | Naarden, Netherlands | ||
Healthequity is engaged in healthcare innovation through strategic investments. | healthequity.es | Barcelona, Spain | ||
Capital is provided to firms for growth, buyouts, and acquisitions. | 2001 | anderapartners.com | Paris, France | |
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors | 1953 | edmond-de-rothschild.com | Paris, France |
Investor details for Sanifit
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sanifit
7 people are tracked at Sanifit (5 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Joan Perelló | Chief Executive Officer | Leadership |
Marisa Guitart | Head, Business Operations | Leadership |
Alexander M. Gold | CMO | Leadership |
Antonio Jiménez | General Counsel & VP, Operations | Leadership |
Laurence H. Keller | VP, Clinical Development | Leadership |
Carolina Salcedo | CSO | Team |
Marco Antonio Moreno | SVP, Manufacturing | Team |
Complete people profiles for Sanifit
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sanifit
4 dated milestones of Sanifit across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Sanifit is founded.
- Funding First funding round of $4.8M.
- Funding Latest funding round, Series D, of $82.1M.
- Exit Acquired by Vifor Pharma Benelux.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sanifit
Complete news archive for Sanifit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanifit
Sanifit was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Sanifit is headquartered in Palma, Spain. It is registered at Palma, Balearic Islands, Spain.
Sanifit is a funded company, having raised a total of $127.72M across 4 funding rounds to date. The company's 1st funding round was a Series B of $4.79M, raised on Aug 2014.
Sanifit was founded in 2007 in Palma, Spain, and operates in the biopharmaceutical sector. Treatments for calcification disorders are developed, with SNF472 as the lead compound targeting cardiovascular calciphylaxis and end-stage renal disease in hemodialysis patients. The pipeline includes ASB-01 for oral tartar prevention, SNF671 tablets for bone health in osteoporosis, and Lit-Control, a device for renal lithiasis monitoring through urinary pH control.
Sanifit has 12 investors. Key investors include Baxter, Edmond de Rothschild, Andera Partners, CSL Vifor, and Caixa Capital Risc.
Yes. Sanifit was acquired by Vifor Pharma Benelux in November 2021.